IMMUNOSUPPRESSION
Clinical trials for IMMUNOSUPPRESSION explained in plain language.
Never miss a new study
Get alerted when new IMMUNOSUPPRESSION trials appear
Sign up with your email to follow new studies for IMMUNOSUPPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug help sepsis patients with weak immune systems?
Disease control Not yet recruitingThis Phase 2 trial tests whether adding the drug nogapendekin alfa inbakicept (NAI) to standard sepsis care can improve survival in critically ill adults with sepsis and persistently low lymphocyte counts (a sign of immune suppression). About 50 participants will be randomly assi…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug aims to stop kidney rejection
Disease control Not yet recruitingThis early study tests a new medicine called TNX-1500 in 5 people who get a kidney transplant. The goal is to see if it is safe and can help prevent the body from rejecting the new kidney. Participants will be followed for one year to check for side effects and signs of rejection…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE2 • Sponsor: Ayman Al Jurdi, MD • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC